rs267608406
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 4P and 12B. PM1PM4BP6_Very_StrongBS2
The NM_001110792.2(MECP2):c.1198_1215del(p.Pro400_Pro405del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000747 in 803,418 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★★). Synonymous variant affecting the same amino acid position (i.e. P400P) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.000097 ( 0 hom., 3 hem., cov: 0)
Exomes 𝑓: 0.000075 ( 0 hom. 20 hem. )
Failed GnomAD Quality Control
Consequence
MECP2
NM_001110792.2 inframe_deletion
NM_001110792.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.37
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM1
?
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 13 benign, 11 uncertain in NM_001110792.2
PM4
?
Nonframeshift variant in NON repetitive region in NM_001110792.2.
BP6
?
Variant X-154030648-CGGGCTCAGGTGGAGGTGG-C is Benign according to our data. Variant chrX-154030648-CGGGCTCAGGTGGAGGTGG-C is described in ClinVar as [Likely_benign]. Clinvar id is 143396.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chrX-154030648-CGGGCTCAGGTGGAGGTGG-C is described in Lovd as [Pathogenic]. Variant chrX-154030648-CGGGCTCAGGTGGAGGTGG-C is described in Lovd as [Benign].
BS2
?
High Hemizygotes in GnomAdExome at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.1198_1215del | p.Pro400_Pro405del | inframe_deletion | 3/3 | ENST00000453960.7 | |
MECP2 | NM_004992.4 | c.1162_1179del | p.Pro388_Pro393del | inframe_deletion | 4/4 | ENST00000303391.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000303391.11 | c.1162_1179del | p.Pro388_Pro393del | inframe_deletion | 4/4 | 1 | NM_004992.4 | P1 | |
MECP2 | ENST00000453960.7 | c.1198_1215del | p.Pro400_Pro405del | inframe_deletion | 3/3 | 1 | NM_001110792.2 | ||
MECP2 | ENST00000407218.5 | c.*534_*551del | 3_prime_UTR_variant | 4/4 | 5 | ||||
MECP2 | ENST00000628176.2 | c.*534_*551del | 3_prime_UTR_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.00 AC: 7AN: 72333Hom.: 0 Cov.: 0 AF XY: 0.000187 AC XY: 3AN XY: 16021 FAILED QC
GnomAD3 genomes
?
AF:
AC:
7
AN:
72333
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
16021
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000408 AC: 7AN: 171619Hom.: 0 AF XY: 0.0000480 AC XY: 3AN XY: 62443
GnomAD3 exomes
AF:
AC:
7
AN:
171619
Hom.:
AF XY:
AC XY:
3
AN XY:
62443
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000747 AC: 60AN: 803418Hom.: 0 AF XY: 0.0000820 AC XY: 20AN XY: 243984
GnomAD4 exome
AF:
AC:
60
AN:
803418
Hom.:
AF XY:
AC XY:
20
AN XY:
243984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? Data not reliable, filtered out with message: AS_VQSR AF: 0.0000968 AC: 7AN: 72333Hom.: 0 Cov.: 0 AF XY: 0.000187 AC XY: 3AN XY: 16021
GnomAD4 genome
?
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
7
AN:
72333
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
16021
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:6
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 14, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | curation | RettBASE | Nov 01, 2011 | - - |
Rett syndrome Benign:2
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Dec 22, 2021 | The allele frequency of the p.Pro388_Pro393del (NM_004992.3) variant in MECP2 is 0.01% in the African/African American sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro388_Pro393del variant is observed in at least 1 unaffected individual (PMID 21160487)(BS2_supporting). The p.Pro388_Pro393del variant is found in a patient with an alternate molecular basis of disease (PMID 21160487)(BP5). In summary, the p.Pro388_Pro393del variant in MECP2 is classified as likely benign based on the ACMG/AMP criteria (BS1, BS2_supporting, BP5). - |
Likely benign, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Aug 14, 2023 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as likely benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). The variant is observed in at least 1 individual with no features of Rett Syndrome (BS2_Supporting). Variant is found in an individual with an alternate molecular basis of disease (BP5). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2018 | - - |
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Aug 02, 2023 | - - |
MECP2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at